Healthcare Industry News: ZELTIQ
News Release - March 6, 2019
Patricia Altavilla Appointed as Chief Executive Officer at Suneva MedicalCompany Advances into Next Phase of Regenerative Aesthetics with Industry Veteran
SAN DIEGO, March 6, 2019 -- (Healthcare Sales & Marketing Network) -- Suneva® Medical, Inc., privately held aesthetics company, announces Chief Executive Officer, Patricia Altavilla as successor to Preston Romm.
Throughout her career she has been instrumental in developing global marketing strategies, building physician loyalty, enhancing practice development, launching innovative products, and increasing the company's industry presence. She has consistently led negotiations for joint ventures, strategic partnerships and distribution relationships in an effort to continue to advance the companies' positions in the market place.
"As we redefine Suneva Medical's position within the industry as leaders in Regenerative Aesthetics, I am honored to help pave the way for the company, further shaping the future of our brand," said Altavilla. "With our introduction of two new products and continuing to build the success of our flagship product Bellafill, it is an exciting time for Suneva Medical."
About Suneva Medical, Inc.
Suneva Medical is a privately-held aesthetics company focused on developing, manufacturing and commercializing novel, differentiated products for the aesthetic markets. The innovative aesthetics leader markets Bellafill®, the only dermal filler on the market that is approved by the U.S. Food and Drug Administration for the correction of nasolabial folds and moderate to severe, atrophic, distensible facial acne scars on the cheek in patients over the age of 21 years old. The company markets Bellafill® in the U.S., Canada, Hong Kong, Korea and Mexico. For more information, visit www.sunevamedical.com.
Source: Suneva Medical
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.